BLRX logo

BioLineRx (BLRX) Total Debt

Annual Total Debt

$11.59 M
-$733.00 K-5.95%

31 December 2023

BLRX Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$29.61 M
-$1.64 M-5.25%

30 September 2024

BLRX Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLRX Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.0%+122.4%
3 y3 years+50.9%+446.2%
5 y5 years+32.7%+172.0%

BLRX Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-6.0%+149.2%-5.3%+1032.9%
5 y5 years-6.0%+149.2%-5.3%+1032.9%
alltimeall time-6.0%-5.3%

BioLineRx Total Debt History

DateAnnualQuarterly
Sept 2024
-
$29.61 M(-5.3%)
June 2024
-
$31.25 M(+176.3%)
Mar 2024
-
$11.31 M(-2.4%)
Dec 2023
$11.59 M(-5.9%)
$11.59 M(-12.9%)
Sept 2023
-
$13.31 M(-1.7%)
June 2023
-
$13.54 M(+5.1%)
Mar 2023
-
$12.88 M(+4.5%)
Dec 2022
$12.32 M(+165.0%)
$12.32 M(+14.0%)
Sept 2022
-
$10.81 M(+313.7%)
June 2022
-
$2.61 M(-29.5%)
Mar 2022
-
$3.71 M(-20.3%)
Dec 2021
$4.65 M(-39.5%)
$4.65 M(-14.2%)
Sept 2021
-
$5.42 M(-13.0%)
June 2021
-
$6.24 M(-9.0%)
Mar 2021
-
$6.85 M(-10.9%)
Dec 2020
$7.68 M(-26.5%)
$7.68 M(-7.7%)
Sept 2020
-
$8.32 M(-7.8%)
June 2020
-
$9.03 M(-6.8%)
Mar 2020
-
$9.69 M(-7.3%)
Dec 2019
$10.46 M(+19.7%)
$10.46 M(-4.0%)
Sept 2019
-
$10.89 M(+1.3%)
June 2019
-
$10.75 M(+0.6%)
Mar 2019
-
$10.69 M(+22.4%)
Dec 2018
$8.73 M(+3393.2%)
$8.73 M(+4778.8%)
Sept 2018
-
$179.00 K(-11.4%)
June 2018
-
$202.00 K(-10.6%)
Mar 2018
-
$226.00 K(-9.6%)
Dec 2017
$250.00 K
$250.00 K(-8.4%)
Sept 2017
-
$273.00 K(-7.8%)
DateAnnualQuarterly
June 2017
-
$296.00 K(-7.5%)
Mar 2017
-
$320.00 K(-6.7%)
Dec 2016
$343.00 K(-21.5%)
$343.00 K(-6.0%)
Sept 2016
-
$365.00 K(-6.2%)
June 2016
-
$389.00 K(-5.8%)
Mar 2016
-
$413.00 K(-5.5%)
Dec 2015
$437.00 K(>+9900.0%)
$437.00 K(-4.8%)
Sept 2015
-
$459.00 K(>+9900.0%)
June 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sept 2014
-
$0.00(0.0%)
June 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
Sept 2013
-
$0.00(0.0%)
June 2013
-
$0.00(-100.0%)
Mar 2013
-
$14.80 K(-59.7%)
Dec 2012
$36.70 K(-66.5%)
$36.70 K(-16.0%)
Sept 2012
-
$43.70 K(-32.7%)
June 2012
-
$64.90 K(-28.0%)
Mar 2012
-
$90.10 K(-17.8%)
Dec 2011
$109.60 K(>+9900.0%)
$109.60 K(-17.6%)
Sept 2011
-
$133.00 K(-21.3%)
June 2011
-
$169.10 K(-10.1%)
Mar 2011
-
$188.20 K(>+9900.0%)
Dec 2010
$0.00
$0.00(0.0%)
Sept 2010
-
$0.00(0.0%)
June 2010
-
$0.00(0.0%)
Mar 2010
-
$0.00

FAQ

  • What is BioLineRx annual total debt?
  • What is the all time high annual total debt for BioLineRx?
  • What is BioLineRx annual total debt year-on-year change?
  • What is BioLineRx quarterly total debt?
  • What is the all time high quarterly total debt for BioLineRx?
  • What is BioLineRx quarterly total debt year-on-year change?

What is BioLineRx annual total debt?

The current annual total debt of BLRX is $11.59 M

What is the all time high annual total debt for BioLineRx?

BioLineRx all-time high annual total debt is $12.32 M

What is BioLineRx annual total debt year-on-year change?

Over the past year, BLRX annual total debt has changed by -$733.00 K (-5.95%)

What is BioLineRx quarterly total debt?

The current quarterly total debt of BLRX is $29.61 M

What is the all time high quarterly total debt for BioLineRx?

BioLineRx all-time high quarterly total debt is $31.25 M

What is BioLineRx quarterly total debt year-on-year change?

Over the past year, BLRX quarterly total debt has changed by +$16.30 M (+122.44%)